News

SMS Pharmaceuticals Limited will hold a board meeting on Wednesday, November 4, 2026, to consider and approve the unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2026, according to a regulatory filing with the BSE Limited and National Stock Exchange of India Ltd. The company has closed the trading window for its equity shares for designated persons, including directors, from October 1, 2026, until November 6, 2026, and will reopen it on November 7, 2026.

SMS Pharmaceuticals Limited informed the BSE Limited and National Stock Exchange of India Ltd that it has received a certificate from Aarthi Consultants Private Limited, Hyderabad, confirming compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter and half year ended September 30, 2026.

SMS Pharmaceuticals Limited informed the Bombay Stock Exchange and National Stock Exchange of India that the trading window for dealing in the company`s shares will be closed for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of financial results for the second quarter and half year ended September 30, 2026, in accordance with SEBI regulations and the company`s code of conduct.

SMS Pharmaceuticals Limited informed the BSE Limited and National Stock Exchange of India Ltd. that the company`s 38th Annual General Meeting, previously scheduled for Wednesday, September 23, 2026, will now be held on Tuesday, September 29, 2026, via video conferencing or other audio-visual means, with a record date for dividend eligibility set for Tuesday, September 22, 2026, and a book closure from Wednesday, September 23, 2026, to Tuesday, September 29, 2026.

SMS Pharmaceuticals announced that the 38th Annual General Meeting(AGM) of the company will be held on 23 September 2026.